What is Community Health Systems, Inc.'s earnings per share (EPS)?

Community Health Systems, Inc. (CYH) reported diluted earnings per share of $3.77 for fiscal year 2025. This represents a 196.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Community Health Systems, Inc. (CYH) Financials

CYH

Trailing 12 months to June 30, 2026

Revenue $12.0B -5.2% YoY

Net Income $252.0M +230.6% YoY

EPS (Diluted) $1.84 +224.3% YoY

Free Cash Flow -$185.0M -236.0% YoY

Market Cap $389.2M as of Oct 6, 2026

Price / Sales 0.0x on $12.0B revenue, trailing 12 months to June 30, 2026

Price / Earnings 1.5x on $252.0M net income, trailing 12 months to June 30, 2026

Price / Book n/m negative shareholder equity, so no book multiple, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 23, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CYH SEC filings page.

Community Health Systems, Inc. (CYH) reported $12.0B in revenue over the twelve months to Jun 30, 2026, down 5.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CYH FY2025 2026-10-04

Flat revenue, sharply better margins, and positive free cash flow show a business recovering through cost structure rather than volume growth.

The FY2024 net loss coexisted with positive operating cash flow, whereas FY2025's return to profitability came with operating cash flow of $543M. That earnings-and-cash convergence, alongside free cash flow improving from $120M to $208M, suggests the latest recovery was not merely an accrual-based accounting swing.

Revenue was nearly flat across FY2024-FY2025, while operating margin rose from 4.3% to 11.9%. With SG&A essentially unchanged, the margin step-up points to lower direct costs and better operating conversion, not volume growth.

Long-term debt fell from $11.4B to $10.4B, but equity remained negative at -$1.4B and the current ratio was 1.5x. The business is reducing leverage while still operating with a thin book-capital cushion.

Financial Health Signals

Financial Health Score 39/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Community Health Systems, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Community Health Systems, Inc. has an operating margin of 11.9%, meaning the company retains $12 of operating profit per $100 of revenue. This results in a moderate score of 63/100, indicating healthy but not exceptional operating efficiency. This is up from 4.3% the prior year.

Growth

Community Health Systems, Inc.'s revenue declined 1.2% year-over-year, from $12.6B to $12.5B. This contraction results in a growth score of 30/100.

Leverage

Liquidity

Community Health Systems, Inc.'s current ratio of 1.46 indicates adequate short-term liquidity, earning a score of 40/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Community Health Systems, Inc.'s free cash flow margin of 1.7% results in a low score of 27/100. Capital expenditures of $335.0M absorb a large share of operating cash flow.

Returns

Altman Z-Score Distress

1.05

Community Health Systems, Inc. scores 1.05, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

9/9

Community Health Systems, Inc. passes 9 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.07x

For every $1 of reported earnings, Community Health Systems, Inc. generates $1.07 in operating cash flow ($543.0M OCF vs $509.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

1.71x

Community Health Systems, Inc. earns $1.71 in operating income for every $1 of interest expense ($1.5B vs $872.0M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.8B

YoY-9.8%

QoQ-4.7%

5Y CAGR-1.2%

Community Health Systems, Inc. generated $2.8B in revenue in Q2 2026. This represents a decrease of 9.8% from the same quarter a year earlier. Against the prior quarter it is down 4.7%.

EBITDA

$497.0M

YoY-19.4%

QoQ+25.8%

5Y CAGR+2.1%

Community Health Systems, Inc.'s EBITDA was $497.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 19.4% from the same quarter a year earlier. Against the prior quarter it is up 25.8%.

Net Income

$70.0M

YoY-75.2%

QoQ+220.7%

5Y CAGR+63.5%

Community Health Systems, Inc. reported $70.0M in net income in Q2 2026. This represents a decrease of 75.2% from the same quarter a year earlier. Against the prior quarter it is up 220.7%.

EPS (Diluted)

$0.51

YoY-75.6%

QoQ+218.6%

5Y CAGR+66.4%

Community Health Systems, Inc. earned $0.51 per diluted share (EPS) in Q2 2026. This represents a decrease of 75.6% from the same quarter a year earlier. Against the prior quarter it is up 218.6%.

Cash & Balance Sheet

Free Cash Flow

$12.0M

YoY+500.0%

QoQ+103.2%

5Y CAGR-30.1%

10Y CAGR-22.6%

Community Health Systems, Inc. generated $12.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 500.0% from the same quarter a year earlier. Against the prior quarter it is up 103.2%.

Cash & Debt

$149.0M

YoY-67.3%

QoQ-79.1%

5Y CAGR-34.6%

10Y CAGR-10.7%

Community Health Systems, Inc. held $149.0M in cash against $9.6B in long-term debt as of Q2 2026.

Shares Outstanding

141M

YoY+0.6%

QoQ+0.1%

5Y CAGR+1.3%

10Y CAGR+2.2%

Community Health Systems, Inc. had 141M shares outstanding in Q2 2026. This represents an increase of 0.6% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

85.8%

YoY+0.8pp

QoQ+0.7pp

5Y change+2.4pp

Community Health Systems, Inc.'s gross margin was 85.8% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.7 percentage points.

Operating Margin

13.8%

YoY-2.6pp

QoQ+4.3pp

5Y change+3.3pp

Community Health Systems, Inc.'s operating margin was 13.8% in Q2 2026, reflecting core business profitability. This is down 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.3 percentage points.

Net Margin

2.5%

YoY-6.5pp

QoQ+4.4pp

5Y change+2.3pp

Community Health Systems, Inc.'s net profit margin was 2.5% in Q2 2026, showing the share of revenue converted to profit. This is down 6.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.4 percentage points.

Return on Equity

Not reported for Q2 2026.

Capital Allocation

Capital Expenditures

$76.0M

YoY-16.5%

QoQ0.0%

5Y CAGR-6.6%

10Y CAGR-8.4%

Community Health Systems, Inc. invested $76.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 16.5% from the same quarter a year earlier. It is unchanged from the prior quarter.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

CYH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CYH quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$12.0B	$12.5B-1.2%	$12.6B+1.2%	$12.5B+2.3%	$12.2B-1.3%	$12.4B+4.9%	$11.8B-10.8%	$13.2B-6.7%	$14.2B-7.8%	$15.4B-16.7%	$18.4B	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	$1.7B	$1.9B-4.2%	$1.9B-2.4%	$2.0B+0.9%	$2.0B-3.3%	$2.0B+4.0%	$2.0B-8.7%	$2.2B-8.7%	$2.4B-11.9%	$2.7B-11.3%	$3.0B	N/A	N/A	N/A	N/A	N/A
Gross Profit	$10.2B	$10.6B-0.6%	$10.7B+1.8%	$10.5B+2.5%	$10.2B-0.9%	$10.3B+5.1%	$9.8B-11.1%	$11.1B-6.3%	$11.8B-6.9%	$12.7B-17.8%	$15.4B	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$5.3B	$5.4B-0.1%	$5.4B+0.1%	$5.4B+1.6%	$5.3B+1.7%	$5.2B-3.1%	$5.4B-9.0%	$5.9B-6.8%	$6.4B-13.4%	$7.4B-14.5%	$8.6B-4.1%	$9.0B+4.3%	$8.6B+41.1%	$6.1B+1.9%	$6.0B+9.6%	$5.5B
Operating Income	$1.4B	$1.5B+174.5%	$542.0M-43.4%	$957.0M+16.6%	$821.0M-41.4%	$1.4B+24.5%	$1.1B+73.2%	$650.0M+212.5%	$208.0M+111.1%	-$1.9B-118.4%	-$860.0M-164.3%	$1.3B-0.1%	$1.3B+46.0%	$917.0M-25.2%	$1.2B+7.2%	$1.1B
EBITDA	N/A	$1.9B+86.2%	$1.0B-29.7%	$1.5B+7.9%	$1.4B-30.2%	$1.9B+15.3%	$1.7B+33.9%	$1.3B+38.5%	$908.0M+189.3%	-$1.0B-523.8%	$240.0M-90.4%	$2.5B-0.6%	$2.5B+48.6%	$1.7B-12.9%	$2.0B+8.4%	$1.8B
Interest Expense	$859.0M	$872.0M+1.0%	$863.0M+3.7%	$832.0M-3.3%	$860.0M-2.8%	$885.0M-14.2%	$1.0B-1.0%	$1.0B+6.7%	$976.0M+4.8%	$931.0M-3.2%	$962.0M-1.1%	$973.0M+0.1%	$972.0M+58.5%	$613.1M-1.3%	$621.0M-3.4%	$642.5M
Income Tax	$53.0M	$48.0M-39.2%	$79.0M-58.6%	$191.0M+12.4%	$170.0M+29.8%	$131.0M+170.8%	-$185.0M-215.6%	$160.0M+1554.5%	-$11.0M+97.6%	-$449.0M-331.7%	-$104.0M-189.7%	$116.0M+41.5%	$82.0M-21.2%	$104.0M-36.6%	$164.0M+15.8%	$141.6M
Net Income	$252.0M	$509.0M+198.6%	-$516.0M-288.0%	-$133.0M-389.1%	$46.0M-80.0%	$230.0M-55.0%	$511.0M+175.7%	-$675.0M+14.3%	-$788.0M+68.0%	-$2.5B-42.9%	-$1.7B-1189.2%	$158.0M+71.7%	$92.0M-34.8%	$141.0M-47.0%	$266.0M+31.7%	$201.9M
EPS (Basic)	N/A	$3.81+197.7%	-$3.90-282.4%	-$1.02-391.4%	$0.35-80.8%	$1.82-58.9%	$4.43+174.7%	-$5.93+15.2%	-$6.99+68.2%	-$22.00-41.6%	-$15.54-1226.1%	$1.38+68.3%	$0.82-46.1%	$1.52-49.0%	$2.98+33.0%	$2.24
EPS (Diluted)	$1.84	$3.77+196.7%	-$3.90-282.4%	-$1.02-391.4%	$0.35-80.1%	$1.76-59.9%	$4.39+174.0%	-$5.93+15.2%	-$6.99+68.2%	-$22.00-41.6%	-$15.54-1234.3%	$1.37+67.1%	$0.82-45.7%	$1.51-49.0%	$2.96+32.7%	$2.23
Diluted Shares (Avg)	N/A	135M+2.2%	132M+1.3%	130M+0.3%	130M-0.4%	131M+12.1%	117M+2.5%	114M+0.9%	113M+0.9%	112M+0.9%	111M-3.9%	115M+2.4%	113M+20.0%	94M+4.5%	90M-0.9%	91M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$2.8B-9.8%	$3.0B-6.1%	$3.1B-4.8%	$3.1B-0.1%	$3.1B-0.2%	$3.2B+0.6%	$3.3B+2.6%	$3.1B+0.1%
Cost of Revenue	$401.0M-14.5%	$441.0M-9.8%	$446.0M-12.0%	$460.0M-1.9%	$469.0M-2.9%	$489.0M+0.4%	$507.0M+2.8%	$469.0M-4.1%
Gross Profit	$2.4B-9.0%	$2.5B-5.5%	$2.7B-3.5%	$2.6B+0.2%	$2.7B+0.3%	$2.7B+0.6%	$2.8B+2.6%	$2.6B+0.9%
SG&A Expenses	$1.2B-6.8%	$1.3B-3.6%	$1.4B-0.4%	$1.4B-0.2%	$1.3B-0.2%	$1.4B+0.3%	$1.4B-0.9%	$1.4B+1.6%
Operating Income	$389.0M-24.0%	$281.0M-1.1%	$449.0M+61.5%	$243.0M+218.5%	$512.0M+115.1%	$284.0M+22.9%	$278.0M-15.2%	-$205.0M-218.5%
EBITDA	$497.0M-19.4%	$395.0M+1.5%	$557.0M+36.9%	$351.0M+498.9%	$617.0M+70.0%	$389.0M+12.4%	$407.0M-9.4%	-$88.0M-129.2%
Interest Expense	$207.0M-3.7%	$214.0M-2.3%	$221.0M+0.9%	$217.0M0.0%	$215.0M-0.5%	$219.0M+3.8%	$219.0M+4.3%	$217.0M+4.3%
Income Tax	$76.0M-35.6%	$89.0M+111.9%	$61.0M-33.0%	-$173.0M-170.3%	$118.0M+391.7%	$42.0M+50.0%	$91.0M-15.7%	-$64.0M-436.8%
Net Income	$70.0M-75.2%	-$58.0M-346.2%	$110.0M+254.9%	$130.0M+133.2%	$282.0M+2269.2%	-$13.0M+68.3%	-$71.0M-251.1%	-$391.0M-329.7%
EPS (Basic)	$0.51-75.8%	-$0.43-330.0%	$0.82+257.7%	$0.97+132.9%	$2.11+2210.0%	-$0.10+68.8%	-$0.52-244.4%	-$2.95-327.5%
EPS (Diluted)	$0.51-75.6%	-$0.43-330.0%	$0.80+253.8%	$0.96+132.5%	$2.09+2190.0%	-$0.10+68.8%	-$0.52-244.4%	-$2.95-327.5%
Diluted Shares (Avg)	137M+1.2%	134M+1.2%	N/A	135M+2.1%	135M+1.9%	133M+1.2%	N/A	132M+1.3%

Not reported in any period shown, so not listed: R&D Expenses.

CYH Balance Sheet

CYH quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$13.2B-6.0%	$14.1B-2.8%	$14.5B-1.5%	$14.7B-3.6%	$15.2B-4.9%	$16.0B+2.5%	$15.6B-1.6%	$15.9B-9.1%	$17.4B-20.5%	$21.9B-17.5%	$26.6B-3.0%	$27.4B+60.2%	$17.1B+3.1%	$16.6B+9.2%	$15.2B
Current Assets	$3.2B-2.0%	$3.3B+2.9%	$3.2B+4.1%	$3.1B-11.4%	$3.5B-22.9%	$4.5B+31.6%	$3.4B-3.4%	$3.5B-12.8%	$4.1B-12.8%	$4.7B-9.7%	$5.2B-7.2%	$5.6B+48.5%	$3.7B+9.6%	$3.4B+20.1%	$2.8B
Cash & Equivalents	$260.0M+602.7%	$37.0M-2.6%	$38.0M-67.8%	$118.0M-76.7%	$507.0M-69.7%	$1.7B+675.9%	$216.0M+10.2%	$196.0M-65.2%	$563.0M+136.6%	$238.0M+29.3%	$184.0M-63.9%	$509.0M+36.5%	$373.0M-3.9%	$388.0M+198.5%	$130.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$2.1B-9.1%	$2.3B+2.5%	$2.2B+9.4%	$2.0B-1.1%	$2.1B+7.0%	$1.9B-14.7%	$2.3B-4.0%	$2.4B-1.3%	$2.4B-24.9%	$3.2B-12.0%	$3.6B+5.9%	$3.4B+46.7%	$2.3B+14.2%	$2.0B+10.9%	$1.8B
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$3.3B-12.5%	$3.8B-4.3%	$4.0B-5.0%	$4.2B-1.3%	$4.2B0.0%	$4.2B-2.5%	$4.3B-5.1%	$4.6B-3.5%	$4.7B-27.6%	$6.5B-27.3%	$9.0B+0.2%	$9.0B+102.3%	$4.4B+0.8%	$4.4B+3.4%	$4.2B
Total Liabilities	$14.0B-8.7%	$15.4B+0.6%	$15.3B-0.8%	$15.4B-3.9%	$16.0B-6.1%	$17.1B-1.1%	$17.2B+2.6%	$16.8B-4.5%	$17.6B-10.4%	$19.7B-10.3%	$21.9B-3.9%	$22.8B+67.4%	$13.6B+1.4%	$13.4B+8.9%	$12.3B
Current Liabilities	$2.2B-5.8%	$2.3B+9.5%	$2.1B-2.0%	$2.2B-7.5%	$2.4B-16.0%	$2.8B+23.4%	$2.3B-4.6%	$2.4B+1.5%	$2.4B-18.4%	$2.9B-6.0%	$3.1B-14.4%	$3.6B+46.0%	$2.5B+14.7%	$2.1B+12.2%	$1.9B
Non-Current Liabilities	$11.8B-9.2%	$13.0B-0.8%	$13.1B-0.6%	$13.2B-3.3%	$13.7B-4.1%	$14.2B-4.8%	$15.0B+3.7%	$14.4B-5.5%	$15.3B-9.0%	$16.8B-11.0%	$18.8B-1.9%	$19.2B+72.1%	$11.2B-1.1%	$11.3B+8.2%	$10.4B
Long-Term Debt	$10.4B-9.2%	$11.4B-0.3%	$11.5B-1.3%	$11.6B-4.1%	$12.1B+0.1%	$12.1B-9.7%	$13.4B-0.1%	$13.4B-3.5%	$13.9B-6.1%	$14.8B-10.7%	$16.6B-0.7%	$16.7B+79.6%	$9.3B-1.7%	$9.5B+7.6%	$8.8B
Total Equity	-$1.4B+27.2%	-$1.9B-37.5%	-$1.4B-1.8%	-$1.4B+0.4%	-$1.4B+15.6%	-$1.6B+26.7%	-$2.2B-44.5%	-$1.5B-100.1%	-$767.0M-147.5%	$1.6B-59.8%	$4.0B+0.4%	$4.0B+30.5%	$3.1B+12.3%	$2.7B+13.9%	$2.4B
Retained Earnings	-$3.6B+12.5%	-$4.1B-14.5%	-$3.6B-3.9%	-$3.4B+1.3%	-$3.5B+6.2%	-$3.7B+12.1%	-$4.2B-19.1%	-$3.5B-28.3%	-$2.8B-823.4%	-$299.0M-114.0%	$2.1B+8.0%	$2.0B+4.9%	$1.9B+8.1%	$1.7B+16.2%	$1.5B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$12.2B-10.7%	$13.2B-5.1%	$13.2B-6.0%	$13.2B-4.8%	$13.6B-5.3%	$13.9B-3.7%	$14.1B-2.8%	$13.9B-5.2%
Current Assets	$3.1B-15.8%	$3.8B+10.7%	$3.2B-2.0%	$3.2B+2.9%	$3.7B+14.4%	$3.4B+7.3%	$3.3B+2.9%	$3.1B-4.3%
Cash & Equivalents	$149.0M-67.3%	$712.0M+65.2%	$260.0M+602.7%	$123.0M+272.7%	$456.0M+1069.2%	$431.0M+797.9%	$37.0M-2.6%	$33.0M-63.7%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$2.1B-5.2%	$2.1B-8.0%	$2.1B-9.1%	$2.2B+5.7%	$2.3B+3.0%	$2.3B+6.0%	$2.3B+2.5%	$2.0B-5.4%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$3.2B-10.4%	$3.1B-17.3%	$3.3B-12.5%	$3.5B-10.2%	$3.6B-9.3%	$3.8B-4.3%	$3.8B-4.3%	$3.9B-0.1%
Total Liabilities	$13.0B-11.7%	$14.1B-7.1%	$14.0B-8.7%	$14.2B-6.5%	$14.7B-3.6%	$15.2B-0.5%	$15.4B+0.6%	$15.2B-2.5%
Current Liabilities	$2.0B-12.2%	$2.6B+8.3%	$2.2B-5.8%	$2.2B+2.4%	$2.3B+5.7%	$2.4B+11.0%	$2.3B+9.5%	$2.1B-1.1%
Non-Current Liabilities	$11.0B-11.6%	$11.6B-9.9%	$11.8B-9.2%	$12.0B-7.9%	$12.4B-5.1%	$12.8B-2.4%	$13.0B-0.8%	$13.0B-2.8%
Long-Term Debt	$9.6B-11.9%	$10.1B-10.4%	$10.4B-9.2%	$10.6B-7.7%	$10.8B-5.8%	$11.3B-2.0%	$11.4B-0.3%	$11.5B-3.0%
Total Equity	-$1.4B+14.8%	-$1.5B+24.4%	-$1.4B+27.2%	-$1.5B+17.6%	-$1.6B-13.2%	-$1.9B-34.7%	-$1.9B-37.5%	-$1.8B-24.6%
Retained Earnings	-$3.6B+6.6%	-$3.6B+11.4%	-$3.6B+12.5%	-$3.7B+8.2%	-$3.8B-5.3%	-$4.1B-13.5%	-$4.1B-14.5%	-$4.0B-11.0%

Not reported in any period shown, so not listed: Inventory.

CYH Cash Flow Statement

CYH quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$126.0M	$543.0M+13.1%	$480.0M+128.6%	$210.0M-30.0%	$300.0M+329.0%	-$131.0M-106.0%	$2.2B+465.7%	$385.0M+40.5%	$274.0M-64.6%	$773.0M-32.0%	$1.1B+23.5%	$921.0M-43.0%	$1.6B+48.3%	$1.1B-14.9%	$1.3B+1.4%	$1.3B
Depreciation & Amortization	N/A	$426.0M-12.3%	$486.0M-3.8%	$505.0M-5.4%	$534.0M-1.1%	$540.0M-3.2%	$558.0M-8.2%	$608.0M-13.1%	$700.0M-18.7%	$861.0M-21.7%	$1.1B-6.3%	$1.2B-1.1%	$1.2B+51.6%	$783.0M+7.9%	$726.0M+10.4%	$657.7M
Stock-Based Compensation	N/A	$11.0M-35.3%	$17.0M-22.7%	$22.0M+10.0%	$20.0M-20.0%	$25.0M+92.3%	$13.0M+30.0%	$10.0M-23.1%	$13.0M-45.8%	$24.0M-47.8%	$46.0M-22.0%	$59.0M+9.3%	$54.0M+42.1%	$38.0M-7.3%	$41.0M-3.6%	$42.5M
Capital Expenditures	$311.0M	$335.0M-6.9%	$360.0M-22.9%	$467.0M+12.5%	$415.0M-11.5%	$469.0M+6.6%	$440.0M+0.5%	$438.0M-16.9%	$527.0M-6.6%	$564.0M-24.2%	$744.0M-21.9%	$953.0M+11.7%	$853.0M+38.9%	$614.0M-20.2%	$769.0M-1.0%	$776.7M
Free Cash Flow	-$185.0M	$208.0M+73.3%	$120.0M+146.7%	-$257.0M-123.5%	-$115.0M+80.8%	-$600.0M-134.5%	$1.7B+3379.2%	-$53.0M+79.1%	-$253.0M-221.1%	$209.0M-46.8%	$393.0M+1328.1%	-$32.0M-104.2%	$762.0M+60.4%	$475.0M-7.0%	$511.0M+5.3%	$485.2M
Investing Cash Flow	$1.1B	$847.0M+408.0%	-$275.0M-957.7%	-$26.0M+90.0%	-$259.0M+50.6%	-$524.0M-396.0%	$177.0M+8950.0%	-$2.0M+99.2%	-$245.0M-122.9%	$1.1B+69.7%	$630.0M+159.9%	-$1.1B+75.8%	-$4.4B-339.1%	-$991.0M+28.3%	-$1.4B-15.7%	-$1.2B
Financing Cash Flow	-$1.5B	-$1.2B-466.5%	-$206.0M+22.0%	-$264.0M+38.6%	-$430.0M+16.3%	-$514.0M+42.6%	-$895.0M-146.6%	-$363.0M+8.3%	-$396.0M+73.9%	-$1.5B+11.4%	-$1.7B-778.5%	-$195.0M-106.8%	$2.9B+2641.6%	-$113.0M-131.3%	$361.0M+253.3%	-$235.4M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$22.5M	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$159.0M+1666.7%	$9.0M-66.7%	$27.0M	N/A	$85.8M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$88.0M0.0%	-$297.0M-347.5%	$266.0M+23.1%	$69.0M+3.0%	$88.0M-12.9%	$120.0M+25.0%	$216.0M+140.0%	$67.0M+131.0%
Depreciation & Amortization	$108.0M+2.9%	$114.0M+8.6%	$109.0M-15.5%	$108.0M-7.7%	$105.0M-16.0%	$105.0M-8.7%	$129.0M+6.6%	$117.0M-8.6%
Stock-Based Compensation	$2.0M-33.3%	$3.0M-25.0%	N/A	-$1.0M-125.0%	$3.0M+50.0%	$4.0M-33.3%	N/A	$4.0M-33.3%
Capital Expenditures	$76.0M-16.5%	$76.0M-10.6%	$94.0M-13.8%	$65.0M-7.1%	$91.0M+3.4%	$85.0M-8.6%	$109.0M-0.9%	$70.0M-46.2%
Free Cash Flow	$12.0M+500.0%	-$373.0M-1165.7%	$172.0M+60.7%	$4.0M+233.3%	-$3.0M-123.1%	$35.0M+1066.7%	$107.0M+635.0%	-$3.0M+97.0%
Investing Cash Flow	-$23.0M-106.7%	$1.0B+130.4%	$142.0M+199.3%	-$81.0M-208.0%	$342.0M+416.7%	$444.0M+548.5%	-$143.0M-179.4%	$75.0M+174.3%
Financing Cash Flow	-$628.0M-55.1%	-$274.0M-61.2%	-$271.0M-292.8%	-$321.0M-116.9%	-$405.0M-20150.0%	-$170.0M-1407.7%	-$69.0M+78.6%	-$148.0M-428.9%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

CYH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CYH quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	85.1%+0.5pp	84.6%+0.6pp	84.0%+0.2pp	83.8%+0.3pp	83.5%+0.1pp	83.4%-0.4pp	83.7%+0.4pp	83.4%+0.8pp	82.6%-1.1pp	83.7%	N/A	N/A	N/A	N/A	N/A
Operating Margin	11.9%+7.6pp	4.3%-3.4pp	7.7%+0.9pp	6.7%-4.6pp	11.3%+1.8pp	9.6%+4.6pp	4.9%+3.5pp	1.5%+13.7pp	-12.2%-7.6pp	-4.7%	N/A	N/A	N/A	N/A	N/A
Net Margin	4.1%+8.2pp	-4.1%-3.0pp	-1.1%-1.4pp	0.4%-1.5pp	1.9%-2.5pp	4.3%+9.4pp	-5.1%+0.5pp	-5.6%+10.5pp	-16.0%-6.7pp	-9.3%	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-106.6%-110.5pp	3.9%+1.6pp	2.3%-2.3pp	4.6%-5.1pp	9.7%+1.3pp	8.4%
Return on Assets	3.9%+7.5pp	-3.7%-2.8pp	-0.9%-1.2pp	0.3%-1.2pp	1.5%-1.7pp	3.2%+7.5pp	-4.3%+0.6pp	-5.0%+9.1pp	-14.1%-6.3pp	-7.8%-8.4pp	0.6%+0.3pp	0.3%-0.5pp	0.8%-0.8pp	1.6%+0.3pp	1.3%
Current Ratio	1.46+0.1x	1.41-0.1x	1.50+0.1x	1.41-0.1x	1.47-0.1x	1.60+0.1x	1.500.0x	1.48-0.2x	1.73+0.1x	1.62-0.1x	1.68+0.1x	1.550.0x	1.52-0.1x	1.59+0.1x	1.49
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	9.16+5.0x	4.120.0x	4.17+1.1x	3.03-0.4x	3.46-0.2x	3.66
Asset Turnover	0.950.0x	0.900.0x	0.860.0x	0.830.0x	0.81+0.1x	0.74-0.1x	0.850.0x	0.890.0x	0.880.0x	0.84	N/A	N/A	N/A	N/A	N/A
FCF Margin	1.7%+0.7pp	0.9%+3.0pp	-2.1%-1.1pp	-0.9%+3.9pp	-4.9%-19.6pp	14.7%+15.1pp	-0.4%+1.4pp	-1.8%-3.1pp	1.4%-0.8pp	2.1%	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	85.8%+0.8pp	85.1%+0.6pp	85.6%+1.2pp	85.1%+0.3pp	85.0%+0.4pp	84.5%0.0pp	84.5%0.0pp	84.8%+0.7pp
Operating Margin	13.8%-2.6pp	9.5%+0.5pp	14.5%+5.9pp	7.9%+14.5pp	16.3%+8.8pp	9.0%+1.6pp	8.5%-1.8pp	-6.6%-12.2pp
Net Margin	2.5%-6.5pp	-2.0%-1.6pp	3.5%+5.7pp	4.2%+16.9pp	9.0%+9.4pp	-0.4%+0.9pp	-2.2%-3.7pp	-12.7%-9.7pp
Return on Assets	0.6%-1.5pp	-0.4%-0.4pp	0.8%+1.3pp	1.0%+3.8pp	2.1%+2.2pp	-0.1%+0.2pp	-0.5%-0.8pp	-2.8%-2.2pp
Current Ratio	1.53-0.1x	1.470.0x	1.46+0.1x	1.470.0x	1.59+0.1x	1.440.0x	1.41-0.1x	1.460.0x
Asset Turnover	0.230.0x	0.230.0x	0.240.0x	0.230.0x	0.230.0x	0.230.0x	0.230.0x	0.220.0x
FCF Margin	0.4%+0.5pp	-12.6%-13.7pp	5.5%+2.3pp	0.1%+0.2pp	-0.1%-0.5pp	1.1%+1.0pp	3.3%+3.9pp	-0.1%+3.2pp

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Note: Shareholder equity is negative (-$1.4B), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Community Health Systems, Inc. CYH	FY2025	$12.5B	$509.0M	4.1%	$389.2M	39/100
Enhabit, Inc. EHAB	FY2025	$1.1B	-$4.6M	-0.4%	$706.9M	28/100
Auna S.A. AUNA	FY2025	N/A	N/A	N/A	$374.7M	—
Cross Country Healthcare Inc CCRN	FY2025	$1.1B	-$94.9M	-9.0%	$428.1M	41/100
agilon health, inc. AGL	FY2025	$5.9B	-$391.3M	-6.6%	$1.4B	39/100
AirSculpt Technologies, Inc. AIRS	FY2025	$151.8M	-$11.7M	-7.7%	$127.6M	29/100

Where Community Health Systems, Inc. Ranks

Frequently Asked Questions

What is Community Health Systems, Inc.'s annual revenue?

Community Health Systems, Inc. (CYH) reported $12.5B in total revenue for fiscal year 2025. This represents a -1.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Community Health Systems, Inc.'s revenue growing?

Community Health Systems, Inc. (CYH) revenue declined by 1.2% year-over-year, from $12.6B to $12.5B in fiscal year 2025.

Is Community Health Systems, Inc. profitable?

Yes, Community Health Systems, Inc. (CYH) reported a net income of $509.0M in fiscal year 2025, with a net profit margin of 4.1%.

What is Community Health Systems, Inc.'s EBITDA?

Community Health Systems, Inc. (CYH) had EBITDA of $1.9B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Community Health Systems, Inc. have?

As of fiscal year 2025, Community Health Systems, Inc. (CYH) had $260.0M in cash and equivalents against $10.4B in long-term debt.

What is Community Health Systems, Inc.'s gross margin?

Community Health Systems, Inc. (CYH) had a gross margin of 85.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Community Health Systems, Inc.'s operating margin?

Community Health Systems, Inc. (CYH) had an operating margin of 11.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Community Health Systems, Inc.'s net profit margin?

Community Health Systems, Inc. (CYH) had a net profit margin of 4.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Community Health Systems, Inc.'s free cash flow?

Community Health Systems, Inc. (CYH) generated $208.0M in free cash flow during fiscal year 2025. This represents a 73.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Community Health Systems, Inc.'s operating cash flow?

Community Health Systems, Inc. (CYH) generated $543.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Community Health Systems, Inc.'s total assets?

Community Health Systems, Inc. (CYH) had $13.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Community Health Systems, Inc.'s capital expenditures?

Community Health Systems, Inc. (CYH) invested $335.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Community Health Systems, Inc. have outstanding?

Community Health Systems, Inc. (CYH) had 139M shares outstanding as of fiscal year 2025.

What is Community Health Systems, Inc.'s current ratio?

Community Health Systems, Inc. (CYH) had a current ratio of 1.46 as of fiscal year 2025, which is considered adequate.

What is Community Health Systems, Inc.'s return on assets (ROA)?

Community Health Systems, Inc. (CYH) had a return on assets of 3.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Community Health Systems, Inc.'s P/E ratio?

Community Health Systems, Inc. (CYH) trades at 1.5x earnings, its market capitalization divided by net income of $252.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $389.2M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Community Health Systems, Inc.'s price-to-sales ratio?

Community Health Systems, Inc. (CYH) trades at 0.0x sales, its market capitalization divided by revenue of $12.0B revenue, trailing 12 months to June 30, 2026. The market capitalization is $389.2M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Why is Community Health Systems, Inc.'s debt-to-equity ratio negative or not reported?

Community Health Systems, Inc. (CYH) has negative shareholder equity of -$1.4B as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Community Health Systems, Inc.'s Altman Z-Score?

Community Health Systems, Inc. (CYH) has an Altman Z-Score of 1.05, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Community Health Systems, Inc.'s Piotroski F-Score?

Community Health Systems, Inc. (CYH) has a Piotroski F-Score of 9 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Community Health Systems, Inc.'s earnings high quality?

Community Health Systems, Inc. (CYH) has an earnings quality ratio of 1.07x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Community Health Systems, Inc. cover its interest payments?

Community Health Systems, Inc. (CYH) has an interest coverage ratio of 1.71x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Community Health Systems, Inc.?

Community Health Systems, Inc. (CYH) scores 39 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.